BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 16019624)

  • 21. [Dithranol and combined treatment procedures: pro and con].
    Mahrle G; Schulze HJ; Steigleder GK
    Hautarzt; 1985 Jan; 36(1):34-9. PubMed ID: 3972577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of maintenance narrow-band ultraviolet B therapy on the duration of remission for psoriasis: a prospective randomized clinical trial.
    Boztepe G; Karaduman A; Sahin S; Hayran M; Kölemen F
    Int J Dermatol; 2006 Mar; 45(3):245-50. PubMed ID: 16533223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcitriol vs. dithranol in combination with narrow-band ultraviolet B (311 nm) in psoriasis.
    Hofmann UB; Eggert AA; Bröcker EB; Goebeler M
    Br J Dermatol; 2003 Apr; 148(4):779-83. PubMed ID: 12752138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Puerto Rico psoriasis study group: efficacy and safety of etanercept.
    González-Chavez JR; Berlingeri-Ramos AC; Sánchez Casiano MA
    J Drugs Dermatol; 2005; 4(6):735-9. PubMed ID: 16302559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial experience with routine administration of etanercept in psoriasis.
    de Groot M; Appelman M; Spuls PI; de Rie MA; Bos JD
    Br J Dermatol; 2006 Oct; 155(4):808-14. PubMed ID: 16965432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of long-wave ultraviolet light in Goeckerman treatment.
    Marsico AR; Eaglstein WH
    Arch Dermatol; 1973 Jul; 108(1):48-9. PubMed ID: 4716741
    [No Abstract]   [Full Text] [Related]  

  • 27. Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis.
    Maryles S; Rozenblit M; Lebwohl M
    J Dermatolog Treat; 2003; 14 Suppl 2():7-16. PubMed ID: 14578093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psoriasis of the scalp. Diagnosis and management.
    van de Kerkhof PC; Franssen ME
    Am J Clin Dermatol; 2001; 2(3):159-65. PubMed ID: 11705093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of psoriasis.
    Cowen P
    Aust Fam Physician; 2001 Nov; 30(11):1033-7. PubMed ID: 11759451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The treatment of psoriasis in a day care center].
    de Hoop D; van Andel P; de Kort WJ; Heinhuis J; van Vloten WA; de Korte J
    Ned Tijdschr Geneeskd; 1990 Jun; 134(25):1220-3. PubMed ID: 2385298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman's therapy.
    Andrys C; Borska L; Pohl D; Fiala Z; Hamakova K; Krejsek J
    Arch Dermatol Res; 2007 Mar; 298(10):479-83. PubMed ID: 17221216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose narrow-band UVB phototherapy combined with topical therapy is effective in psoriasis and does not inhibit systemic T-cell activation.
    de Rie MA; Out TA; Bos JD
    Dermatology; 1998; 196(4):412-7. PubMed ID: 9669117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug interactions in psoriasis: the pros and cons of combining topical psoriasis therapies.
    Endzweig-Gribetz CH; Brady C; Lynde C; Sibbald D; Lebwohl M
    J Cutan Med Surg; 2002; 6(3 Suppl):12-6. PubMed ID: 11976987
    [No Abstract]   [Full Text] [Related]  

  • 34. Prescribing in psoriasis.
    Berth-Jones J
    Practitioner; 1994 Mar; 238(1536):231-4. PubMed ID: 8183808
    [No Abstract]   [Full Text] [Related]  

  • 35. Psoriasis therapy: a current perspective.
    Lowe NJ
    West J Med; 1983 Aug; 139(2):184-9. PubMed ID: 6195826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tar photoxicity and phototherapy for psoriasis.
    Tanenbaum L; Parrish JA; Pathak MA; Anderson RR; Fitzpatrick TB
    Arch Dermatol; 1975 Apr; 111(4):467-70. PubMed ID: 1122147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Updating the Goeckerman regimen for psoriasis.
    Petrozzi JW; Barton JO; Kaidbey KK; Kligman AM
    Br J Dermatol; 1978 Apr; 98(4):437-44. PubMed ID: 638049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and side effects of UVB-phototherapy, dithranol inpatient therapy and a care instruction programme of short contact dithranol in moderate to severe psoriasis.
    Sminkels OQ; Prins M; Veeniiuis RT; De Boo T; Gerritsen MJ; Van Der Wilt GJ; Van De Kerkhof PC; Van Der Valk PG
    Eur J Dermatol; 2004; 14(3):159-65. PubMed ID: 15246941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
    van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
    Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An attempt to formulate an evidence-based strategy in the management of moderate-to-severe psoriasis: a review of the efficacy and safety of biologics and prebiologic options.
    Leon A; Nguyen A; Letsinger J; Koo J
    Expert Opin Pharmacother; 2007 Apr; 8(5):617-32. PubMed ID: 17376017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.